Michael Cannon, an expert on health care policy, discusses the growing issue of government overreach in the healthcare sector. He critiques the lack of substantial reform plans from both Donald Trump and Kamala Harris, pointing out their failure to address the inefficacy of current government interventions. The conversation dives into the opaque nature of healthcare pricing and the importance of consumer empowerment to foster transparency and lower costs. Cannon emphasizes that without meaningful change, fiscal burdens will only increase.

Brian Blase, chief of Paragon Health Institute, and Michael Cannon from Cato discuss the fiscal challenges of Medicare. They explore funding issues, lobbying dynamics, and propose reforms for cost control and quality care. The podcast highlights the resistance to cutting Medicare spending, misconceptions about the Medicare Trust Fund, and the impact of recent legislation on rising debt levels.

Michael Cannon, a FDA policy expert discusses the impact of FDA's delays in approving contraception on women's economic gains. They explore how FDA regulations create barriers to access and affordability, and the negative impact of FDA's delays on drug approval and prices.